🇺🇸 FDA
Patent

US 12053491

Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

granted A61KA61K2039/505A61K2239/29

Quick answer

US patent 12053491 (Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20) held by The Regents of the University of California expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61K2239/29, A61K2239/48, A61K35/17